Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPTE2 pseudogene 6 (TPTE2P6) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene (in this case, TPTE2) but is generally non-functional and does not encode a protein. The TPTE2 gene, to which it is related, encodes a transmembrane phosphoinositide 3-phosphatase with tensin homology 2, which is involved in phosphoinositide metabolism. However, TPTE2P6 itself does not encode an active enzyme or receptor, and there is no evidence that it plays a role as a therapeutic target or has direct biological, disease, or pharmacological relevance[3][5]. Its primary significance is in the genomic context and evolutionary studies of PTEN/TPTE-related gene families, as some pseudogenes in other gene families can act as competitive endogenous RNAs (ceRNAs), but there is no specific evidence for such a function for TPTE2P6[2][3].\nKey clarifications:\n- TPTE2P6 is a pseudogene, does not encode a protein, and has no validated function as a receptor, enzyme, transporter, or other canonical drug target class.\n- There are no approved or known drugs, mechanisms of action, or direct biomarker or clinical utility associated with TPTE2P6.\n- This entry is likely not a therapeutic target itself and may be included by mistake when seeking validated molecular targets. If you are looking for information on related functional phosphatases, TPTE2 or PTEN genes should be considered instead[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPTE2 pseudogene 6 (TPTE2P6).